Biotech FDA approves expanded pediatric indications for YUFLYMA® (adalimumab-aaty) and unbranded adalimumab-aaty in the United States October 17, 2025
Biotech HistoIndex to debut FibroSIGHT™ Plus and showcase latest scientific findings at AASLD The Liver Meeting® 2025 October 15, 2025
Biotech 10x Faster Virus Neutralization Testing With Launch of Integral Molecular’s Ready Reporter Virus™ Kit October 14, 2025
Biotech EY announces the acquisition of Aqurance to accelerate life science transformation on Veeva technology October 13, 2025
Biotech C-Ray Therapeutics (Chengdu) Co., Ltd Congratulates Partner Biokin Pharmaceutical on NMPA IND Approval of First Proprietary ARC Drug [177Lu]-BL-ARC001 October 12, 2025
Biotech Development of the First Inner Ear Organoids by 3D Bioprinting for Pharmacological Screening in Hearing Disorders: CTIBIOTECH™ Announces Strategic Agreement With SATT AxLR and CILCARE October 11, 2025
Biotech Alamar Biosciences Launches NULISAqpcr™ BD-pTau217 Assay: A Breakthrough in Non-Invasive, Brain-Specific Biomarker Detection for Alzheimer’s Disease Research October 10, 2025
Biotech Chance Pharma Announces Commercialization Agreement with Huadong Medicine for Innovative Respiratory Drug CXG87 October 9, 2025
Biotech Complement Therapeutics Receives FDA IND Clearance to Advance CTx001 into Opti-GAIN, a Phase I/II Clinical Trial in Geographic Atrophy secondary to AMD October 8, 2025
Search
Biotech
October 17, 2025
October 16, 2025
October 15, 2025
October 14, 2025
October 13, 2025
![C-Ray Therapeutics (Chengdu) Co., Ltd Congratulates Partner Biokin Pharmaceutical on NMPA IND Approval of First Proprietary ARC Drug [177Lu]-BL-ARC001](https://bullstockresearch.com/wp-content/uploads/2025/10/0f732339608839df309acb5e78eab100-336x223.jpg)
October 12, 2025
October 11, 2025
October 10, 2025
October 9, 2025
October 8, 2025
